Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

23.09
-0.1983-0.85%
Post-market: 23.08-0.0107-0.05%17:14 EDT
Volume:2K
Turnover:51.46K
Market Cap:4.62M
PE:- -
High:23.41
Open:23.41
Low:23.08
Close:23.29
52wk High:24.20
52wk Low:15.00
Shares:200.00K
Float Shares:200.00K
Volume Ratio:1.90
T/O Rate:1.11%
Dividend:0.77
Dividend Rate:3.34%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

TIPRANKS
·
Sep 09

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

TIPRANKS
·
Sep 08

Press Release: Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer

Dow Jones
·
Sep 08

AlzeCure Pharma to Present at Aktiedagen Event in Stockholm

Reuters
·
Sep 08

The Second Act of Biotech

TIPRANKS
·
Sep 07

ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review

Reuters
·
Sep 07

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Reuters
·
Sep 07

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 05

Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch

TIPRANKS
·
Sep 05

Dow Jones Top Company Headlines at 9 am ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...

Dow Jones
·
Sep 04

Moderna Chief Legal Officer Shannon Thyme Klinger Disposes of USD 485,271.45 in Common Shares

Reuters
·
Sep 04

Cboe data shows mixed options sentiment in Moderna with shares down 3.87%

TIPRANKS
·
Sep 04

Eli Lilly Stock (LLY) Gets a Bullish Note from JPMorgan Chase

TIPRANKS
·
Sep 04

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 04

Why Moderna Stock's Cancer Vaccine Rally Sparked a Rare Sell Rating

Dow Jones
·
Sep 03

Aspen Sees Mounjaro Africa Sales Above $124 Million in 2027

Reuters
·
Sep 03

Superluminal Medicines: Financing Led by Bvf Partners; Alongside Existing Investors Nvidia, Eli Lilly & Co, Cooley, and Gaingels, Among Others

THOMSON REUTERS
·
Sep 03

Rothschild & Co Redburn Adjusts PT on Eli Lilly and Co. to $930 From $915, Keeps Neutral Rating

MT Newswires Live
·
Sep 03

Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40

MT Newswires Live
·
Sep 03

Transgene Jumps 20% on Positive Cancer Vaccine Data in Early Trial

Reuters
·
Sep 03